OR WAIT null SECS
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
By Tom Brody, DNAX Research Institute, pp. 38-42. Early sale or offers to sell an invention may result in the rejection of a patent application under 35 U.S.C. 102(b). Such a rejection is called "the on-sale bar," and it permanently prevents patenting of an invention.